Back

Dapagliflozin prevents fibrogenic activation in endocardial endothelial cells under altered flow

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Adult congenital heart disease: medical treatment Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speakers

Photo
Ms Julia Gaal

Boston Children's Hospital, Boston (United States of America)

Photo
Doctor Ingeborg Friehs

Boston Children's Hospital, Boston (United States of America)

8 More presentations in this session

Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitors for the treatment of single ventricle circulatory failure in adults with congenital heart disease
Doctor R. Neijenhuis (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Results of CHASM IN ACHD (peer CoacHing Adaptive Self-Management INterventions for young Adults with Congenital Heart Disease) study
Doctor R. Krasuski (Durham, US)
Abstract Slides Video
Presentation thumbnail
Sacubitril/ valsartan in patients with congenital heart disease: a systematic review and meta-analysis
Doctor D. Ntiloudi (Pireas, GR)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose cotransporter-2 inhibitor use in children with left ventricular systolic dysfunction: a matched case-control analysis
Doctor D. Newland (Seattle, US)
Abstract Slides Video
Presentation thumbnail
Impact on adverse events of guideline-directed medical therapy for heart failure in patients with a systemic right ventricle
Doctor I. Altobelli (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Adult congenital heart disease: medical treatment

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Dapagliflozin's influence on cardiac remodeling in chronic heart failure patients
thumbnail
Congress Presentation
Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
The effect of dapagliflozin on the microvascular endothelial cell function and metabolism in patients with heart failure: a preliminary report

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources